[Therapy of severe pulmonary hypertension with prostacyclin and iloprost].
Matthes
J
J
Institut für Pharmakologie der Universität zu Köln.
Mathen
F
F
Herzig
S
S
Wassermann
K
K
D000959:Antihypertensive Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D011464:Epoprostenol / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D006439:Hemodynamics / Q000187:drug effects; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D016285:Iloprost / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D011379:Prognosis; D014665:Vasodilator Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D014665:Vasodilator Agents; D011464:Epoprostenol; D016285:Iloprost